Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 18, 2022

SELL
$7.06 - $13.97 $78,888 - $156,100
-11,174 Closed
0 $0
Q1 2022

Apr 11, 2022

BUY
$12.15 - $35.28 $47,154 - $136,921
3,881 Added 53.22%
11,174 $136,000
Q4 2021

Jan 19, 2022

BUY
$30.49 - $48.49 $1,585 - $2,521
52 Added 0.72%
7,293 $249,000
Q3 2021

Oct 08, 2021

BUY
$41.66 - $52.52 $3,749 - $4,726
90 Added 1.26%
7,241 $349,000
Q2 2021

Jul 13, 2021

BUY
$36.62 - $51.69 $17,467 - $24,656
477 Added 7.15%
7,151 $323,000
Q1 2021

Apr 14, 2021

BUY
$41.56 - $59.88 $5,859 - $8,443
141 Added 2.16%
6,674 $322,000
Q4 2020

Feb 11, 2021

BUY
$36.08 - $56.47 $235,710 - $368,918
6,533 New
6,533 $352,000

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $2.07B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Veriti Management LLC Portfolio

Follow Veriti Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Veriti Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Veriti Management LLC with notifications on news.